Antihyperlipidemic effects of stilbenoids isolated from Morus alba in rats fed a high-cholesterol diet

Sung Pil Jo, Jeong Keun Kim, Young Hee Lim

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Mulberroside A (MUL) was purified from an ethanol extract of Morus alba root, and oxyresveratrol (OXY) was produced by enzymatic conversion of MUL. Normal rats, Triton WR-1339-induced hyperlipidemic rats, and high-cholesterol diet (HCD)-induced hyperlipidemic rats were orally treated with MUL or OXY (1-5. mg/kg/day). MUL and OXY were administered 1. h prior to concomitant treatment with Triton WR-1339 for a further 24. h, whereas the drugs were administered concurrently with HCD for 4. weeks. Oral MUL and OXY pre-treatment vs. water pre-treatment of Triton WR-1339-induced hyperlipidemic rats significantly (p<. 0.05) reduced the levels of serum lipids in a dose-dependent manner, while high-density lipoprotein cholesterol (HDL-C, or "good" cholesterol) levels were increased. Oral MUL and OXY treatment of HCD-fed rats also showed a significant (p<. 0.05) dose-dependent decrease in serum lipids, coronary artery risk index (CRI), and atherogenic index (AI), but not HDL-C. Furthermore, MUL and OXY treatment of HCD-induced hyperlipidemic rats demonstrated a significant dose-dependent improvement in the histological features of hepatic fatty degeneration. Aspartate aminotransferase and alanine aminotransferase values in OXY-treated normal rats were not significantly different from those in water-treated control rats. These results indicate that MUL and OXY might be developed as novel antihyperlipidemic agents.

Original languageEnglish
Pages (from-to)213-218
Number of pages6
JournalFood and Chemical Toxicology
Volume65
DOIs
Publication statusPublished - 2014 Mar 1

Fingerprint

stilbenoids
Hypolipidemic Agents
Morus
Morus alba
high fat diet
Nutrition
Rats
Cholesterol
Diet
rats
blood lipids
mouth
pretreatment
dosage
Rat control
Lipids
mulberroside A
puag-haad
Water
Water Purification

Keywords

  • Antihyperlipidemic activity
  • Atherogenic index
  • High-cholesterol diet
  • Stilbenoids

ASJC Scopus subject areas

  • Food Science
  • Toxicology

Cite this

Antihyperlipidemic effects of stilbenoids isolated from Morus alba in rats fed a high-cholesterol diet. / Jo, Sung Pil; Kim, Jeong Keun; Lim, Young Hee.

In: Food and Chemical Toxicology, Vol. 65, 01.03.2014, p. 213-218.

Research output: Contribution to journalArticle

@article{8aedf7ecd3e04f378b80f6ba5acf8136,
title = "Antihyperlipidemic effects of stilbenoids isolated from Morus alba in rats fed a high-cholesterol diet",
abstract = "Mulberroside A (MUL) was purified from an ethanol extract of Morus alba root, and oxyresveratrol (OXY) was produced by enzymatic conversion of MUL. Normal rats, Triton WR-1339-induced hyperlipidemic rats, and high-cholesterol diet (HCD)-induced hyperlipidemic rats were orally treated with MUL or OXY (1-5. mg/kg/day). MUL and OXY were administered 1. h prior to concomitant treatment with Triton WR-1339 for a further 24. h, whereas the drugs were administered concurrently with HCD for 4. weeks. Oral MUL and OXY pre-treatment vs. water pre-treatment of Triton WR-1339-induced hyperlipidemic rats significantly (p<. 0.05) reduced the levels of serum lipids in a dose-dependent manner, while high-density lipoprotein cholesterol (HDL-C, or {"}good{"} cholesterol) levels were increased. Oral MUL and OXY treatment of HCD-fed rats also showed a significant (p<. 0.05) dose-dependent decrease in serum lipids, coronary artery risk index (CRI), and atherogenic index (AI), but not HDL-C. Furthermore, MUL and OXY treatment of HCD-induced hyperlipidemic rats demonstrated a significant dose-dependent improvement in the histological features of hepatic fatty degeneration. Aspartate aminotransferase and alanine aminotransferase values in OXY-treated normal rats were not significantly different from those in water-treated control rats. These results indicate that MUL and OXY might be developed as novel antihyperlipidemic agents.",
keywords = "Antihyperlipidemic activity, Atherogenic index, High-cholesterol diet, Stilbenoids",
author = "Jo, {Sung Pil} and Kim, {Jeong Keun} and Lim, {Young Hee}",
year = "2014",
month = "3",
day = "1",
doi = "10.1016/j.fct.2013.12.040",
language = "English",
volume = "65",
pages = "213--218",
journal = "Food and Chemical Toxicology",
issn = "0278-6915",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Antihyperlipidemic effects of stilbenoids isolated from Morus alba in rats fed a high-cholesterol diet

AU - Jo, Sung Pil

AU - Kim, Jeong Keun

AU - Lim, Young Hee

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Mulberroside A (MUL) was purified from an ethanol extract of Morus alba root, and oxyresveratrol (OXY) was produced by enzymatic conversion of MUL. Normal rats, Triton WR-1339-induced hyperlipidemic rats, and high-cholesterol diet (HCD)-induced hyperlipidemic rats were orally treated with MUL or OXY (1-5. mg/kg/day). MUL and OXY were administered 1. h prior to concomitant treatment with Triton WR-1339 for a further 24. h, whereas the drugs were administered concurrently with HCD for 4. weeks. Oral MUL and OXY pre-treatment vs. water pre-treatment of Triton WR-1339-induced hyperlipidemic rats significantly (p<. 0.05) reduced the levels of serum lipids in a dose-dependent manner, while high-density lipoprotein cholesterol (HDL-C, or "good" cholesterol) levels were increased. Oral MUL and OXY treatment of HCD-fed rats also showed a significant (p<. 0.05) dose-dependent decrease in serum lipids, coronary artery risk index (CRI), and atherogenic index (AI), but not HDL-C. Furthermore, MUL and OXY treatment of HCD-induced hyperlipidemic rats demonstrated a significant dose-dependent improvement in the histological features of hepatic fatty degeneration. Aspartate aminotransferase and alanine aminotransferase values in OXY-treated normal rats were not significantly different from those in water-treated control rats. These results indicate that MUL and OXY might be developed as novel antihyperlipidemic agents.

AB - Mulberroside A (MUL) was purified from an ethanol extract of Morus alba root, and oxyresveratrol (OXY) was produced by enzymatic conversion of MUL. Normal rats, Triton WR-1339-induced hyperlipidemic rats, and high-cholesterol diet (HCD)-induced hyperlipidemic rats were orally treated with MUL or OXY (1-5. mg/kg/day). MUL and OXY were administered 1. h prior to concomitant treatment with Triton WR-1339 for a further 24. h, whereas the drugs were administered concurrently with HCD for 4. weeks. Oral MUL and OXY pre-treatment vs. water pre-treatment of Triton WR-1339-induced hyperlipidemic rats significantly (p<. 0.05) reduced the levels of serum lipids in a dose-dependent manner, while high-density lipoprotein cholesterol (HDL-C, or "good" cholesterol) levels were increased. Oral MUL and OXY treatment of HCD-fed rats also showed a significant (p<. 0.05) dose-dependent decrease in serum lipids, coronary artery risk index (CRI), and atherogenic index (AI), but not HDL-C. Furthermore, MUL and OXY treatment of HCD-induced hyperlipidemic rats demonstrated a significant dose-dependent improvement in the histological features of hepatic fatty degeneration. Aspartate aminotransferase and alanine aminotransferase values in OXY-treated normal rats were not significantly different from those in water-treated control rats. These results indicate that MUL and OXY might be developed as novel antihyperlipidemic agents.

KW - Antihyperlipidemic activity

KW - Atherogenic index

KW - High-cholesterol diet

KW - Stilbenoids

UR - http://www.scopus.com/inward/record.url?scp=84892889356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892889356&partnerID=8YFLogxK

U2 - 10.1016/j.fct.2013.12.040

DO - 10.1016/j.fct.2013.12.040

M3 - Article

C2 - 24407019

AN - SCOPUS:84892889356

VL - 65

SP - 213

EP - 218

JO - Food and Chemical Toxicology

JF - Food and Chemical Toxicology

SN - 0278-6915

ER -